Infectious Disease Molecular Diagnostics Global Market Report 2025
상품코드:1810920
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
감염증 분자진단 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연평균 성장률(CAGR) 5.0%로 369억 8,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 현장 검사 도입 확대, 맞춤형 의료에 대한 관심 증가, 감염병 대책에 대한 정부 지원 증가, 신흥 시장에서의 헬스케어 인프라 확대, 호흡기 질환 유병률 증가 등에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 실시간 중합효소 연쇄반응 기술의 발전, 진단 플랫폼의 인공지능 통합 강화, 다중 검사 패널의 개발, 휴대용 및 가정용 진단 키트의 혁신, 분자진단 워크플로우의 자동화 발전 등이 있습니다.
감염병 유행 증가는 향후 감염병 분자진단제 시장의 성장을 촉진할 것으로 예측됩니다. 감염은 세균, 바이러스, 곰팡이, 기생충 등 병원성 미생물에 의해 발생하며, 사람과 사람 사이에 직간접적으로 감염됩니다. 감염증 증가는 주로 세계화와 여행률 증가로 인해 병원체가 국경을 넘어 빠르게 확산되어 국지적 발병이 세계 건강 위기로 발전할 수 있게 되었습니다. 감염성 질환 분자진단은 유전자 수준에서 병원체를 신속하고 정확하게 검출하여 질병 관리를 지원하고, 조기 진단, 표적 치료, 효과적인 발병 통제를 돕습니다. 예를 들어 미국 질병통제예방센터(CDC)에 따르면 2022년 미국에서 보고된 결핵 환자는 8,331명으로 2021년 대비 5.9% 증가했습니다. 따라서 감염병의 확산은 감염병 분자진단 시장 확대에 박차를 가하고 있습니다.
감염병 분자진단 시장의 주요 기업은 실시간 중합효소연쇄반응(PCR) 키트와 같은 혁신적인 솔루션 개발에 주력하고 있으며, 이를 통해 감염성 병원체를 신속하고 정확하게, 높은 처리량으로 검출할 수 있도록 하고 있습니다. 실시간 PCR 키트는 병원체의 특정 유전물질을 실시간으로 동시에 증폭 및 검출하여 감염병을 신속하고 정확하게 확인할 수 있습니다. 예를 들어 2023년 2월 미국의 생명공학 및 생명과학 기업인 Thermo Fisher Scientific Inc.는 인도에서 감염병 검출을 위한 Applied Biosystems TaqPath PCR 키트를 발표했습니다. 이 키트는 리보핵산 추출에서 진단 보고서 작성에 이르는 전체 워크플로우를 통해 감염성 질환 표적의 실시간 PCR 검출을 보통 4시간 이내에 수행하는 신속하고 민감한 다중 진단 솔루션을 제공합니다. 이 키트는 여러 병원체 유전체 영역을 대상으로 하는 다중 분석, 내부 프로세스 제어, 자동 데이터 분석, 사용자 오류를 줄이고 결과의 신뢰성을 향상시키는 다중 분석이 포함되어 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 감염증 분자진단 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 감염증 분자진단 시장 : 성장률 분석
세계의 감염증 분자진단 시장 실적 : 규모와 성장, 2019-2024
세계의 감염증 분자진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 감염증 분자진단 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 감염증 분자진단 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
키트와 시약
기기
소프트웨어와 서비스
세계의 감염증 분자진단 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응
In Situ하이브리다이제이션
등온핵산증폭기술
칩과 마이크로어레이
질량분석
전사 매개 증폭
기타 테크놀러지
세계의 감염증 분자진단 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
호흡기질환
결핵
수막염
소화관 감염증
인유두종바이러스
성감염증
패혈증
약제 내성 질환
기타 용도
세계의 감염증 분자진단 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 임상 검사실
진단 검사실
제약회사
학술연구기관
세계의 감염증 분자진단 시장 : 서브 세분화, 키트와 시약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
디옥시리보핵산 또는 리보핵산 추출 키트
중합효소 연쇄 반응 시약
등온 증폭 키트
프로브 기반 검출 시약
병원체 특이적 어세이 키트
세계의 감염증 분자진단 시장 : 서브 세분화, 기기의 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
실시간 중합효소 연쇄 반응 시스템
등온 증폭 기기
자동 샘플 조제 시스템
차세대 시퀀싱 플랫폼
마이크로어레이 애널라이저
세계의 감염증 분자진단 시장 : 서브 세분화, 소프트웨어와 서비스(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
데이터 분석 및 해석 소프트웨어
연구실 정보 관리 시스템
클라우드 기반 감염증 진단 플랫폼
기기 통합 및 워크플로우 관리툴
바이오인포매틱스 서비스
제7장 지역별·국가별 분석
세계의 감염증 분자진단 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 감염증 분자진단 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
감염증 분자진단 시장 : 경쟁 구도
감염증 분자진단 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Becton Dickinson and Company(BD)
Agilent Technologies Inc.
Hologic Inc.
Illumina Inc.
Biomerieux S.A.
Quidel-Ortho Corporation
Sysmex Corporation
Bio-Rad Laboratories Inc.
QIAGEN N.V.
DiaSorin S.p.A.
Seegene Inc.
Oxford Nanopore Technologies plc
Biocartis NV
T2 Biosystems Inc.
Sherlock Biosciences Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
감염증 분자진단 시장 2029 : 새로운 기회를 제공하는 국가
감염증 분자진단 시장 2029 : 새로운 기회를 제공하는 부문
감염증 분자진단 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Infectious disease molecular diagnostics involves advanced laboratory methods used to detect and identify genetic material from pathogens like bacteria, viruses, fungi, or parasites in patient samples. These diagnostics facilitate rapid and precise diagnosis of infectious diseases, enabling timely treatment and effective disease management.
The primary product categories in infectious disease molecular diagnostics include kits and reagents, instruments, software, and services. Kits and reagents consist of pre-packaged chemical and biological components designed for specific laboratory tests or procedures, such as detecting, measuring, or amplifying genetic material, proteins, or pathogens. Key technologies employed in this area include polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification, chips and microarrays, mass spectrometry, transcription-mediated amplification, among others. These tools are applied to a variety of conditions, including respiratory diseases, tuberculosis, meningitis, gastrointestinal infections, human papillomavirus, sexually transmitted infections, sepsis, and drug-resistant diseases. End users include hospitals and clinical laboratories, diagnostic labs, pharmaceutical companies, and academic and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The infectious disease molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease molecular diagnostics market statistics, including infectious disease molecular diagnostics global market size, regional shares, competitors with infectious disease molecular diagnostics market share, detailed infectious disease molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease molecular diagnostics industry. The infectious disease molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The infectious disease molecular diagnostics market size has grown strongly in recent years. It will grow from $28.95 billion in 2024 to $30.46 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth during the historic period can be attributed to the increasing prevalence of infectious diseases, growing demand for early and accurate diagnosis, the rise in global outbreaks and pandemics, enhanced healthcare awareness and access, and increased investment in diagnostic research and technology.
The infectious disease molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.98 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth projected for the forecast period can be attributed to the increasing adoption of point-of-care testing, a stronger focus on personalized medicine, rising government support for infectious disease control, expanding healthcare infrastructure in emerging markets, and the growing prevalence of respiratory diseases. Key trends expected during this period include advancements in real-time polymerase chain reaction technology, enhanced integration of artificial intelligence in diagnostic platforms, development of multiplex testing panels, innovations in portable and home-based diagnostic kits, and progress in automating molecular diagnostic workflows.
The rising prevalence of infectious diseases is expected to drive growth in the infectious disease molecular diagnostics market going forward. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly between people. The increase in infectious diseases is mainly due to globalization and higher travel rates, enabling pathogens to spread quickly across borders and turn localized outbreaks into global health crises. Molecular diagnostics for infectious diseases support disease management by providing rapid and accurate detection of pathogens at the genetic level, which aids early diagnosis, targeted treatment, and effective outbreak control. For example, according to the US Centers for Disease Control and Prevention, in 2022, the United States reported 8,331 tuberculosis (TB) cases, reflecting a 5.9% increase compared to 2021. Therefore, the growing prevalence of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.
Leading companies in the infectious disease molecular diagnostics market are concentrating on developing innovative solutions such as real-time polymerase chain reaction (PCR) kits, which enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time PCR kits amplify and detect specific genetic material of pathogens simultaneously in real time, allowing for fast and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, introduced Applied Biosystems TaqPath PCR kits for infectious disease detection in India. These kits offer fast, highly sensitive multiplex diagnostic solutions that perform real-time PCR detection of infectious disease targets through a complete workflow-from ribonucleic acid extraction to diagnostic report generation, typically within four hours. The kits include multiplexed assays targeting multiple pathogen genomic regions, internal process controls, and automated data interpretation, which reduces user error and improves reliability of results.
In May 2024, Bruker Corporation, a US-based scientific instrument and analytical technology company, acquired ELITechGroup for $0.94 billion. Through this acquisition, Bruker Corporation aims to enhance its expertise in infectious disease diagnostics by obtaining access to advanced sample-to-answer molecular diagnostic systems and an extensive portfolio of infectious disease assays that complement its existing products. ELITechGroup SAS is a France-based company specializing in infectious disease molecular diagnostics.
Major players in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel Ortho Corporation, Sysmex Corporation, Bio Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., and Sherlock Biosciences Inc.
North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in infectious disease molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the infectious disease molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The infectious disease molecular diagnostics market consists of revenues earned by entities by providing services such as polymerase chain Reaction (PCR) testing, next-generation sequencing, isothermal nucleic acid amplification tests, point-of-care (POC) molecular testing, and viral load monitoring and resistance testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease molecular diagnostics market also includes sales of nucleic acid extraction systems, isothermal amplification assays, multiplex diagnostic panels, molecular diagnostic reagents and consumables, and bloodborne pathogen detection kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Infectious Disease Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on infectious disease molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for infectious disease molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease molecular diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Kits And Reagents; Instruments; Software And Services
2) By Technology: Polymerase Chain Reaction; In Situ Hybridization; Isothermal Nucleic Acid Amplification Technology; Chips And Microarrays; Mass Spectrometry; Transcription Mediated Amplification; Other Technologies
3) By Application: Respiratory Diseases; Tuberculosis; Meningitis; Gastrointestinal Tract Infections; Human Papillomavirus; Sexually Transmitted Infections; Sepsis; Drug Resistance Diseases; Other Applications
4) By End-User: Hospitals And Clinical Laboratories; Diagnostic Laboratories; Pharmaceutical Companies; Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Isothermal Amplification Kits; Probe-Based Detection Reagents; Pathogen-Specific Assay Kits
3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information Management Systems; Cloud-Based Infectious Disease Diagnostic Platforms; Instrument Integration And Workflow Management Tools; Bioinformatics Services
3. Infectious Disease Molecular Diagnostics Market Trends And Strategies
4. Infectious Disease Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Infectious Disease Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Infectious Disease Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Infectious Disease Molecular Diagnostics Market Growth Rate Analysis
5.4. Global Infectious Disease Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Infectious Disease Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Infectious Disease Molecular Diagnostics Total Addressable Market (TAM)
6.1. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits And Reagents
Instruments
Software And Services
6.2. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology
Chips And Microarrays
Mass Spectrometry
Transcription Mediated Amplification
Other Technologies
6.3. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Respiratory Diseases
Tuberculosis
Meningitis
Gastrointestinal Tract Infections
Human Papillomavirus
Sexually Transmitted Infections
Sepsis
Drug Resistance Diseases
Other Applications
6.4. Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinical Laboratories
Diagnostic Laboratories
Pharmaceutical Companies
Academic And Research Institutes
6.5. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits
Polymerase Chain Reaction Reagents
Isothermal Amplification Kits
Probe-based Detection Reagents
Pathogen-Specific Assay Kits
6.6. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction Systems
Isothermal Amplification Instruments
Automated Sample Preparation Systems
Next-Generation Sequencing Platforms
Microarray Analyzers
6.7. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Infectious Disease Molecular Diagnostics Market
9.1. China Infectious Disease Molecular Diagnostics Market Overview
9.2. China Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Infectious Disease Molecular Diagnostics Market
10.1. India Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Infectious Disease Molecular Diagnostics Market
11.1. Japan Infectious Disease Molecular Diagnostics Market Overview
11.2. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Infectious Disease Molecular Diagnostics Market
12.1. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Infectious Disease Molecular Diagnostics Market
13.1. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Infectious Disease Molecular Diagnostics Market
14.1. South Korea Infectious Disease Molecular Diagnostics Market Overview
14.2. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Infectious Disease Molecular Diagnostics Market
15.1. Western Europe Infectious Disease Molecular Diagnostics Market Overview
15.2. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Infectious Disease Molecular Diagnostics Market
16.1. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Infectious Disease Molecular Diagnostics Market
21.1. Eastern Europe Infectious Disease Molecular Diagnostics Market Overview
21.2. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Infectious Disease Molecular Diagnostics Market
22.1. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Infectious Disease Molecular Diagnostics Market
23.1. North America Infectious Disease Molecular Diagnostics Market Overview
23.2. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Infectious Disease Molecular Diagnostics Market
24.1. USA Infectious Disease Molecular Diagnostics Market Overview
24.2. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Infectious Disease Molecular Diagnostics Market
26.1. South America Infectious Disease Molecular Diagnostics Market Overview
26.2. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Infectious Disease Molecular Diagnostics Market
27.1. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Infectious Disease Molecular Diagnostics Market
28.1. Middle East Infectious Disease Molecular Diagnostics Market Overview
28.2. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Infectious Disease Molecular Diagnostics Market
29.1. Africa Infectious Disease Molecular Diagnostics Market Overview
29.2. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Company Profiles
